Placenta
Volume 29, Issue 12 , Pages 1016-1023 , December 2008

Proteomic Analyses Associate Cystatin B with Restricted HIV-1 Replication in Placental Macrophages

  • C. Luciano-Montalvo

      Affiliations

    • Department of Microbiology and Medical Zoology, University of Puerto Rico, Medical Sciences Campus, Puerto Rico
    • ,
  • P. Ciborowski

      Affiliations

    • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA
    • ,
  • F. Duan

      Affiliations

    • Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA
    • ,
  • H.E. Gendelman

      Affiliations

    • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA
    • ,
  • L.M. Meléndez

      Affiliations

    • Department of Microbiology and Medical Zoology, University of Puerto Rico, Medical Sciences Campus, Puerto Rico
    • Specialized Neurosciences Research Program in NeuroAIDS, University of Puerto Rico, Medical Sciences Campus, Puerto Rico
    • Corresponding Author InformationCorresponding author. Specialized Neurosciences Research Program, Biomedical Building I, 3rd Floor, Suite 310, San Juan 00935, Puerto Rico. Tel.: +1 787 758 6132; fax: +1 787 777 0078.

,Accepted 5 September 2008.

References 

  1. Meltzer MS, Gendelman HE. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol. 1992;181:239–263
  2. McGann KA, Collman R, Kolson DL, Gonzalez-Scarano F, Coukos G, Coutifaris C, et al. Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis. 1994;169:746–753
  3. Menu E, Mbopi-Keou FX, Lagaye S, Pissard S, Mauclere P, Scarlatti G, et al. Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1. J Infect Dis. 1999;179:44–51
  4. Patterson BK, Tjernlund A, Andersson J. Endogenous inhibitors of HIV: potent anti-HIV activity of leukemia inhibitory factor. Curr Mol Med. 2002;2:713–722
  5. Kesson AM, Fear WR, Kazazi F, Mathijs JM, Chang J, King NJ, et al. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J Infect Dis. 1993;168:571–579
  6. Melendez-Guerrero LM. In vitro infection of Hofbauer cells with a monocyte-tropic strain of HIV-1. University of Rochester Press, New York; 1994.
  7. Plaud-Valentin M, Delgado R, Garcia V, Zorrilla C, Gandia J, Melendez-Guerrero LM. HIV infection of placental macrophages: effect on the secretion of HIV stimulatory cytokines. Cell Mol Biol (Noisy-le-grand). 1999;45:423–431
  8. Melendez J, Garcia V, Sanchez E, Delgado R, Torres G, Melendez-Guerrero LM. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?. Cell Mol Biol (Noisy-le-grand). 2001;47:Online Pub, OL51-9
  9. Torres G, Garcia V, Sanchez E, Segarra A, Patterson BK, Melendez-Guerrero LM. Expression of the HIV-1 co-receptors CCR5 and CXCR4 on placental macrophages and the effect of IL-10 on their expression. Placenta. 2001;22(Suppl. A):S29–S33
  10. Patterson BK, Behbahani H, Kabat WJ, Sullivan Y, O'Gorman MR, Landay A, et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest. 2001;107:287–294
  11. Lunardi-Iskandar Y, Bryant JL, Blattner WA, Hung CL, Flamand L, Gill P, et al. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med. 1998;4:428–434
  12. Polliotti BM, Gnall-Sazenski S, Laughlin TS, Miller RK. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro. Placenta. 2002;23(Suppl. A):S102–S106
  13. Bourinbaiar AS, Nagorny R. Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts. FEBS Lett. 1992;309:82–84
  14. Ciborowski P, Kadiu I, Rozek W, Smith L, Bernhardt K, Fladseth M, et al. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology. 2007;363:198–209
  15. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988;167:1428–1441
  16. Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, et al. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007;192:157–170
  17. Gimenez-Barcons M, Clotet B, Martinez MA. Endoribonuclease-prepared short interfering RNAs induce effective and specific inhibition of human immunodeficiency virus type 1 replication. J Virol. 2007;81:10680–10686
  18. Beyer S, Walter Y, Hellmann J, Kramer PJ, Kopp-Schneider A, Kroeger M, et al. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF–MS spectra. J Proteome Res. 2006;5:254–261
  19. Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rate: a unified approach. J R Stat Soc Series B. 2004;66:187–205
  20. Zielske SP, Stevenson M. Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol. 2006;80:7275–7280
  21. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol. 2006;80:9039–9052
  22. Kadiu I, Ricardo-Dukelow M, Ciborowski P, Gendelman HE. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J Immunol. 2007;178:6404–6415
  23. Ryckman C, Robichaud GA, Roy J, Cantin R, Tremblay MJ, Tessier PA. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+T lymphocytes. J Immunol. 2002;169:3307–3313
  24. Mazzocco M, Maffei M, Egeo A, Vergano A, Arrigo P, Di Lisi R, et al. The identification of a novel human homologue of the SH3 binding glutamic acid-rich (SH3BGR) gene establishes a new family of highly conserved small proteins related to thioredoxin superfamily. Gene. 2002;291:233–239
  25. Geiben-Lynn R, Kursar M, Brown NV, Addo MM, Shau H, Lieberman J, et al. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem. 2003;278:1569–1574
  26. Nakanishi T, Ozaki Y, Blomgren K, Tateyama H, Sugiura-Ogasawara M, Suzumori K. Role of cathepsins and cystatins in patients with recurrent miscarriage. Mol Hum Reprod. 2005;11:351–355
  27. Divya , Chhikara P, Mahajan VS, Datta Gupta S, Chauhan SS. Differential activity of cathepsin L in human placenta at two different stages of gestation. Placenta. 2002;23:59–64
  28. Varanou A, Withington SL, Lakasing L, Williamson C, Burton GJ, Hemberger M. The importance of cysteine cathepsin proteases for placental development. J Mol Med. 2006;84:305–317
  29. Afonso S, Romagnano L, Babiarz B. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development. 1997;124:3415–3425

PII: S0143-4004(08)00307-X

doi: 10.1016/j.placenta.2008.09.005

Placenta
Volume 29, Issue 12 , Pages 1016-1023 , December 2008

Article Tools

* Image Usage & Resolution